LBA25TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer. (23rd October 2018) - Arkenau, H-T; Tabernero, J; Shitara, K; Dvorkin, M; Mansoor, W; Prokharau, A; Alsina, M; Ghidini, M; Faustino, C; Gorbunova, V; Zhavrid, E A; Nishikawa, K; et al.